Last updated on August 2019

Treatment Protocol for Non-Metastatic Unilateral Retinoblastoma

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Unilateral Retinoblastoma
  • Age: - 6 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Histological diagnosis of retinoblastoma confirmed at participating institutions
  • Ophthalmological diagnosis of unilateral retinoblastoma in patients undergoing conservative therapy.
  • No prior therapy for retinoblastoma
  • Lansky Performance Scale greater or equal to 50
  • Normal organ function in those patients assigned for chemotherapy
  • Signed informed consent

Exclusion Criteria:

  • Patients with unilateral retinoblastoma and germline mutations of the Rb1 gene or family history for retinoblastoma

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Volunteer Sign-up

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.